Cancer Letters

Article	Citations
MDSCs in bone metastasis: Mechanisms and therapeutic potential	200
The landscape of malignant transition: Unraveling cancer cell-of-origin and heterogeneous tissue microenvironment	179
Chaperone directed heterobifunctional molecules circumvent KRASG12C inhibitor resistance	169
A novel mismatch repair deficient lung adenocarcinoma model for immunotherapy research	158
Corrigendum to “Selective degradation of FGFR1/2 overcomes antiestrogen resistance in ER+ breast cancer with FGFR1/2 alterations” [619 1 (2025) 217668 1–13]	154
LCAT deficiency promotes hepatocellular carcinoma progression and lenvatinib resistance by promoting triglyceride catabolism and fatty acid oxidation	131
Editorial Board	128
Combination treatment with 17β-estradiol and anti-PD-L1 suppresses MC38 tumor growth by reducing PD-L1 expression and enhancing M1 macrophage population in MC38 colon tumor model	125
Neoantigen discovery and applications in glioblastoma: An immunotherapy perspective	122
TIM3 on natural killer cells regulates antibody-dependent cellular cytotoxicity in HER2-positive gastric cancer	122
METTL3 regulates M6A methylation-modified EBV-pri-miR-BART3-3p to promote NK/T cell lymphoma growth	121
The stromal microenvironment endows pancreatic neuroendocrine tumors with spatially specific invasive and metastatic phenotypes	115
Tuning cellular metabolism for cancer virotherapy	113
Versatility of Exosomes for Cancer Therapy	112
Bypassing the Tollway; a novel path to TLR4 independent stemness regulation	111
IBI379, a novel B cell maturation antigen/CD3 bispecific T-cell engager, displays high antitumor efficacy in preclinical models of multiple myeloma	110
Ethnic Diversity and Metabolic Variations in Ovarian Cancer Cells: Implications for Personalized Medicine Strategies	107
Editorial Board	105
The E3 ligase TRIM22 functions as a tumor suppressor in breast cancer by targeting CCS for proteasomal degradation to inhibit STAT3 signaling	102
KAT7 enhances the proliferation and metastasis of head and neck squamous carcinoma by promoting the acetylation level of LDHA	100
Nervous system in colorectal cancer	96
Evaluation and preservation of fertility in patients with hematologic malignancies	93
Targeting LINC01607 sensitizes hepatocellular carcinoma to Lenvatinib via suppressing mitophagy	91
Targeted inhibition of the expression of both MCM5 and MCM7 by miRNA-214 impedes DNA replication and tumorigenesis in hepatocellular carcinoma cells	90
Targeting p53 for immune modulation: Exploring its functions in tumor immunity and inflammation	90

Targeted inhibition of acidic nucleoplasmic DNA-binding protein 1 enhances radiosensitivity of non-small cell lung cancer	89
Proteomics and single cell profiling identify keratin driven preexisting immunity influences lung squamous carcinoma neoadjuvant therapy	86
Targeting MKK3/c-Myc interaction to overcome osimertinib acquired resistance in EGFR mutant lung cancer	86
Corrigendum to “Inhibition of Aurora kinases induces apoptosis and autophagy via AURKB/p70S6K/RPL15 axis in human leukemia cells” [Cancer. Lett. (382) 2016-11-28; 382(2):215–230]	86
Intratumoral injection of mRNA encoding survivin in combination with STAT3 inhibitor stattic enhances antitumor effects	86
NSUN2-mediated m5C modification of KDM6B mRNA enhances osteoclast differentiation and promotes breast cancer bone metastasis	82
Metronomic chemotherapy regimens and targeted therapies in non-Hodgkin lymphoma: The best of two worlds	80
Corrigendum to “Identification of metastasis-associated proteins involved in gallbladder carcinoma metastasis by proteomic analysis and functional exploration of chloride intracellular channel 1” [Can	79
Regulation of gut microbiota on immune cell ferroptosis: A novel insight for immunotherapy against tumor	79
Sialic Acids: Sweet modulators fueling cancer cells and domesticating the tumor microenvironment	79
Manganese mediates nucleoplasm distribution of cGAS to enhance systemic antitumor immunity and drive abscopal effect	76
Targeting FOXM1 reshapes antitumor immunity to attenuate small cell lung cancer progression	75
M6A-modified lncRNA FAM83H-AS1 promotes colorectal cancer progression through PTBP1	74
Sphingosine-1 phosphate receptor 1 (S1PR1) expression maintains stemness of acute myeloid leukemia stem cells	74
Unscheduled polyploidy synergizes with oncogenic mutations to enhance genome instability and tumorigenesis	73
Clinical development of immuno-oncology therapeutics	72
Novel role of MKRN2 in regulating tumor growth through host microenvironment and macrophage M1 to M2 switch	72
Hormonal and neuronal interactions shaping the brain metastatic microenvironment	72
CD155 in tumor progression and targeted therapy	72
Accelerating the clinical translation of CD70-targeted chimeric antigen receptor-based cell therapies in oncology: A comprehensive clinical investigation panorama analysis based on the Trialtrove data	72
ASPH dysregulates cell death and induces chemoresistance in hepatocellular carcinoma	71
Tumor-targeted exosomes for delivery of anticancer drugs	70
PI3K inhibitor impairs tumor progression and enhances sensitivity to anlotinib in anlotinib-resistant osteosarcoma	70
An emerging aspect of cancer neuroscience: A literature review on chemotherapy-induced peripheral neuropathy	69
Valproate and lithium: Old drugs for new pharmacological approaches in brain tumors?	67
PROTACs: Novel tools for improving immunotherapy in cancer	66
The role of Hippo/YAP1 in cancer-associated fibroblasts: Literature review and future perspectives	65
Coiled-coil domain-containing 154 promotes colorectal cancer proliferation and metastasis via interacting with minichromosome maintenance complex component 2	65
CD147-specific chimeric antigen receptor T cells effectively inhibit T cell acute lymphoblastic leukemia	64
Selpercatinib mitigates cancer cachexia independent of anti-tumor activity in the HT1080 tumor model	64
Understanding the significance of biological clock and its impact on cancer incidence	63
CSNK2A1 confers gemcitabine resistance to pancreatic ductal adenocarcinoma via inducing autophagy	63
Integrated analysis of ascites and plasma extracellular vesicles identifies a miRNA-based diagnostic signature in ovarian cancer	62
Fatty acids in cancer chemoresistance	62
Hypoxia effects on glioblastoma progression through YAP/TAZ pathway regulation	61
ERBB3 targeting: A promising approach to overcoming cancer therapeutic resistance	60
A natural compound melatonin enhances the effects of Nimotuzumab via inhibiting EGFR in glioblastoma	60
Osteopontin promotes tumor microenvironment remodeling and therapy resistance	60
FAP upregulates PD-L1 expression in cancer-associated fibroblasts to exacerbate T cells dysfunction and suppress anti-tumor immunity	60
Comparable survival outcomes in HLA-Matched and haploidentical hematopoietic stem cell transplantation for severe aplastic anemia patients aged 40–50: A CBMTR Registry-based propensity score matching	60
Increasing membrane polyunsaturated fatty acids sensitizes non-small cell lung cancer to anti-PD-1/PD-L1 immunotherapy	59
The interplay between autophagy and apoptosis: its implication in lung cancer and therapeutics	59
Lactylation-boosted polycomb repression of KLF4 elicits glycolysis in retinoblastoma: A positive feedback circuit between histone modifications	58
R-spondin-3 promotes proliferation and invasion of breast cancer cells independently of Wnt signaling	58
An effective two-stage NMBzA-induced rat esophageal tumor model revealing that the FAT-Hippo-YAP1 axis drives the progression of ESCC	57
Mapping the tumor immune landscape: single-cell RNA sequencing in cancer immunotherapy	57
Overexpression of nucleotide metabolic enzyme DUT in hepatocellular carcinoma potentiates a therapeutic opportunity through targeting its dUTPase activity	56
MEK-mediated CHPF2 phosphorylation promotes colorectal cancer cell proliferation and metastasis by activating NF-κB signaling	56
CircFLNB upregulated by chemotherapy via alternative splicing suppresses the progression of colorectal cancer	56
Inhibition of T-antigen expression promoting glycogen synthase kinase 3 impairs merkel cell carcinoma cell growth	55

Sonrotoclax (BGB-11417) synergistically amplifies the radiotherapy-elicited anti-tumor immune response	55
MLCK inhibition induces synthetic lethality in MYC-driven cancer	55
Breast cancer extracellular vesicles-derived miR-1290 activates astrocytes in the brain metastatic microenvironment via the FOXA2→CNTF axis to promote progression of brain metastases	55
Letter to the editor on ‘A deep neural network predictor to predict the sensitivity of neoadjuvant chemoradiotherapy in locally advanced rectal cancer’	55
Corrigendum to “Discovery of YH677 as a cancer stemness inhibitor that suppresses triple-negative breast cancer growth and metastasis by regulating the TGFβ signaling pathway” [Canc. Lett. (2023) 2161	54
Targeting Amino Acid Dependency for Cancer Treatment	54
Identification and characterization of Bufalin as a novel EGFR degrader	54
Advancing neoadjuvant therapy with inetetamab for HER2-Positive breast cancer	54
FOXF2 expression triggered by endocrine therapy orchestrates therapeutic resistance through reorganization of chromatin architecture in breast cancer	54
Corrigendum to “UBE2T promotes radiation resistance in non-small cell lung cancer via inducing epithelial-mesenchymal transition and the ubiquitination-mediated FOXO1 degradation” [Canc. Lett. 494 (20	53
BCL-2/BCL-XL dual inhibition triggers Gasdermin D-mediated pyroptosis in mantle cell lymphoma	53
A high-affinity antibody-drug conjugates Actuximab-MMAE for potent and selective targeting of CEACAM5-Positive tumors	53
ANKZF1 knockdown inhibits glioblastoma progression by promoting intramitochondrial protein aggregation through mitoRQC	52
Glucose restriction induces ROS-AMPK-mediated CTR1 expression and increases cisplatin efficiency in NSCLC	51
Improved antitumor effects elicited by an oncolytic HSV-1 expressing a novel B7H3nb/CD3 BsAb	51
MicroRNA-21 deficiency suppresses prostate cancer progression through downregulation of the IRS1-SREBP-1 signaling pathway	51
Obese adipose tissue-derived extracellular vesicles enriched with glycolytic cargo promote colorectal cancer tumorigenesis	50
Tumor-derived miR-378a-3p-containing extracellular vesicles promote osteolysis by activating the Dyrk1a/Nfatc1/Angptl2 axis for bone metastasis	50
LKB1 inhibits telomerase activity resulting in cellular senescence through histone lactylation in lung adenocarcinoma	50
Conquering chemoresistance in pancreatic cancer: Exploring novel drug therapies and delivery approaches amidst desmoplasia and hypoxia	50
Claudin-1 interacts with EPHA2 to promote cancer stemness and chemoresistance in colorectal cancer	49
S100A6 drives lymphatic metastasis of liver cancer via activation of the RAGE/NF-kB/VEGF-D pathway	49
Deubiquitinating PABPC1 by USP10 upregulates CLK2 translation to promote tumor progression in pancreatic ductal adenocarcinoma	49
Emerging roles of lysosome homeostasis (repair, lysophagy and biogenesis) in cancer progression and therapy	49
The combination of gemcitabine plus an anti-FGFR inhibitor can have a synergistic antitumor effect on FGF-activating cholangiocarcinoma	48
Nanoparticles in the diagnosis and treatment of cancer metastases: Current and future perspectives	48
Long noncoding RNA lnc-LEMGC combines with DNA-PKcs to suppress gastric cancer metastasis	47
Functional genomic approaches in acute myeloid leukemia: Insights into disease models and the therapeutic potential of reprogramming	47
Corrigendum to “Circular RNA ciRS-7 accelerates ESCC progression through acting as a miR-876-5p sponge to enhance MAGE-A family expression” [Cancer Lett. 426 (2018) 37–46]	47
Mucins as contrast agent targets for fluorescence-guided surgery of pancreatic cancer	47
Editorial Board	47
Editorial Board	47
Corrigendum to “P-REX1 amplification promotes progression of cutaneous melanomavia the PAK1/P38/MMP-2 pathway” [Cancer Lett. 407 (2017) 66–75]	47
DAB2IP suppresses tumor malignancy by inhibiting GRP75-driven p53 ubiquitination in colon cancer	47
LINC00978 regulates metabolic rewiring to promote the malignancy of glioblastoma through AKR1B1	47
Develop a Novel Therapy for Pancreatic Cancer	46
Spermatid perinuclear RNA-binding protein promotes UBR5-mediated proteolysis of Dicer to accelerate triple-negative breast cancer progression	46
PPAR agonists attenuate lenalidomide's anti-myeloma activity in vitro and in vivo	45
WEE1 confers resistance to KRASG12C inhibitors in non-small cell lung cancer	45
Multi-omics analysis unraveling stemness features associated with oncogenic dedifferentiation in 12 cancers	45
A novel molecular subtyping based on multi-omics analysis for prognosis predicting in colorectal melanoma: A 16-year prospective multicentric study	45
Editorial Board	45
Editorial Board	45
Decoding the potential microbiome modulation strategies from bugs to drugs in pancreatic cancer: Insights from clinical trials	45
CircUBE3A(2,3,4,5) promotes adenylate-uridylate-rich binding factor 1 nuclear translocation to suppress prostate cancer metastasis	44
Single-cell RNA-sequencing of human spleens reveals an IDO-1+ tolerogenic dendritic cell subset in pancreatic cancer patients that is absent in normal individuals	44
Novel SARS-CoV-2 inhibition properties of the anti-cancer Kang Guan Recipe herbal formula	44
Gold nanoparticles and obese adipose tissue microenvironment in cancer treatment	44
hnRNPLL regulates MYOF alternative splicing and correlates with early metastasis in pancreatic ductal adenocarcinoma	44
Nanomaterials in crossroad of autophagy control in human cancers: Amplification of cell death mechanisms	44
Early detection and intervention of clonal hematopoiesis for preventing hematological malignancies	43
Low-dose metronomic chemotherapy triggers oxidized mtDNA sensing inside tumor cells to potentiate CD8+T anti-tumor immunity	43
Depression in breast cancer patients: Immunopathogenesis and immunotherapy	43
Remodeling of tumor microenvironment by extracellular matrix protein 1a differentially regulates ovarian cancer metastasis	43
Application prospect of circular RNA-based neoantigen vaccine in tumor immunotherapy	43
Treatment strategies and molecular mechanism of radiotherapy combined with immunotherapy in colorectal cancer	43
Copper in hepatocellular carcinoma： A double-edged sword with therapeutic potentials	43
Human mesenchymal stromal cells maintain their stem cell traits after high-LET particle irradiation – Potential implications for particle radiotherapy and manned space missions	43
The safety and efficacy outcomes of Minnelide given alone or in combination with paclitaxel in advanced gastric cancer: A phase I trial	42
WD repeat protein 54-mediator of ErbB2-driven cell motility 1 axis promotes bladder cancer tumorigenesis and metastasis and impairs chemosensitivity	42
Smoking-induced CCNA2 expression promotes lung adenocarcinoma tumorigenesis by boosting AT2/AT2-like cell differentiation	42
Exercise in cancer prevention and anticancer therapy: Efficacy, molecular mechanisms and clinical information	42
Protective role of epithelial deoxyhypusine synthase in colorectal carcinogenesis caused by deletion of the adenomatous polyposis coli gene	42
GPRC5A promotes gallbladder cancer metastasis by upregulating TNS4 via the JAK2–STAT3 pathway	42
Sorbitol dehydrogenase induction of cancer cell necroptosis and macrophage polarization in the HCC microenvironment suppresses tumor progression	42
Phosphorylation of PBK/TOPK Tyr74 by JAK2 promotes Burkitt lymphoma tumor growth	42
Circular RNA circPFKP promotes cell proliferation by activating IMPDH2 in prostate cancer	42
Targeting WEE1 kinase as a therapeutic strategy in ATIP3-deficient breast cancers	41
SENP1-Sirt3 axis promotes cholesterol biosynthesis in tumor-associated macrophages to suppress anti-tumor immunity	41
Suppressive immune microenvironment and CART therapy for glioblastoma: Future prospects and challenges	41
AI-based radiomic features predict outcomes and the added benefit of chemoimmunotherapy over chemotherapy in extensive stage small cell lung cancer: A multi-institutional study	41
Active immunization with a structurally aggregated PD-L1 antigen breaks T and B immune tolerance in non-human primates and exhibits in vivo anti-tumoral effects in immunocompetent mouse tumor models	41
Mitochondrial fragmentation in liver cancer: Emerging player and promising therapeutic opportunities	41
Shifts in cancer funding: An overview of terminated research grants at the national cancer institute	41
REDD1 is a determinant of the sensitivity of renal cell carcinoma cells to autophagy inhibition that can be therapeutically exploited by targeting PIM activity	41
RNA binding protein RALY activates the cholesterol synthesis pathway through an MTA1 splicing switch in hepatocellular carcinoma	41
Long noncoding RNA KB-1460A1.5 inhibits glioma tumorigenesis via miR-130a-3p/TSC1/mTOR/YY1 feedback loop	41
Radiotherapy-induced tumor physical microenvironment remodeling to overcome immunotherapy resistance	40
The post-chemotherapy changes of tumor physical microenvironment: Targeting extracellular matrix to address chemoresistance	40
Frontiers in pancreatic cancer on biomarkers, microenvironment, and immunotherapy	40

ZC3H13-mediated N6-methyladenosine modification of PHF10 is impaired by fisetin which inhibits the DNA damage response in pancreatic cancer	39
Phase separation of EEF1E1 promotes tumor stemness via PTEN/AKT-mediated DNA repair in hepatocellular carcinoma	39
The feedback loop of AURKA/DDX5/TMEM147-AS1/let-7 drives lipophagy to induce cisplatin resistance in epithelial ovarian cancer	39
Pan-cancer atlas of tumor-resident microbiome, immunity and prognosis	39
Single-cell chemokine receptor profiles delineate the immune contexture of tertiary lymphoid structures in head and neck squamous cell carcinoma	39
Dysregulation of autophagy in gastric carcinoma: Pathways to tumor progression and resistance to therapy	39
Effective leukemia-to-granulocyte induction by a cocktail of RUNX1, SPI1 and CEBPE	38
FUT2-dependent fucosylation of LAMP1 promotes the apoptosis of colorectal cancer cells by regulating the autophagy-lysosomal pathway	38
Tumor-nerve interactions in cancer regulation and progression	38
Dual targeting PPARα and NPC1L1 metabolic vulnerabilities blocks tumorigenesis	38
Corrigendum to “NSUN4 mediated RNA 5-methylcytosine promotes the malignant progression of glioma through improving the CDC42 mRNA stabilization” [Cancer Lett. (2024) 597 217059]	38
TRF2 cooperates with CTCF for controlling the oncomiR-193b-3p in colorectal cancer	38
Interplay among extracellular vesicles, cancer stemness and immune regulation in driving hepatocellular carcinoma progression	38
A journey to excellence: Disseminating groundbreaking discoveries in oncology research	38
Identification of SMARCAL1 as a molecular target for small cell lung cancer treatment	38
Local delivery of optimized nanobodies targeting the PD-1/PD-L1 axis with a self-amplifying RNA viral vector induces potent antitumor responses	38
Non-muscle myosin II isoforms orchestrate substrate stiffness sensing to promote cancer cell contractility and migration	38
Targeted inhibition of CHKα and mTOR in models of pancreatic ductal adenocarcinoma: A novel regimen for metastasis	37
WITHDRAWN: Proteomic analysis of plasma-derived exosomes identifies biomarkers that distinguish brain and liver metastasis in lung cancer patients	37
The mitotic regulator RCC2 promotes glucose metabolism through BACH1-dependent transcriptional upregulation of hexokinase II in glioma	37
Editorial Board	37
Corrigendum to “Scattered DUSP28 is a novel biomarker responsible for aggravating malignancy via the autocrine and paracrine signaling in metastatic pancreatic cancer” [Cancer Lett. 456 (2019 Aug 1) 1	37
Enhanced prediction of breast cancer patient response to chemotherapy by integrating deconvolved expression patterns of immune, stromal and tumor cells	36
Circadian disruption in cancer and regulation of cancer stem cells by circadian clock genes: An updated review	36
Super-giant cells: Toward understanding tumor origins on the organismal level	36
Single-nucleus sequencing unveils heterogeneity in renal cell carcinomas microenvironment: Insights into pathogenic origins and treatment-responsive cellular subgroups	36
CRISPR/Cas9 screen reveals that targeting TRIM34 enhances ferroptosis sensitivity and augments immunotherapy efficacy in hepatocellular carcinoma	36
Letter to the editor regarding “Dual blockade of EGFR and CDK4/6 delays head and neck squamous cell carcinoma progression by inducing metabolic rewiring."	36
Disparities in mortality risk after diagnosis of hematological malignancies in 185 countries: A global data analysis	36
High-content drug screening in zebrafish xenografts reveals high efficacy of dual MCL-1/BCL-XL inhibition against Ewing sarcoma	36
Corrigendum to “Helicobacter pylori upregulates Nanog and Oct4 via Wnt/β-catenin signaling pathway to promote cancer stem cell-like properties in human gastric cancer” [Canc. Lett. 374 (2016) 292–303]	36
Deglycosylated PD-L1 is a biomarker for immune checkpoint blockade response: a real-world study in breast cancer patients in Taiwan	36
Unlocking c-MET: A comprehensive journey into targeted therapies for breast cancer	35
A novel GRK3-HDAC2 regulatory pathway is a key direct link between neuroendocrine differentiation and angiogenesis in prostate cancer progression	35
Deciphering the tumor-suppressive role of PSMB9 in melanoma through multi-omics and single-cell transcriptome analyses	35
CPSF3 regulates alternative polyadenylation of CNIH2 to promote esophageal squamous cell carcinoma progression	35
Neutrophils exposed to a cholesterol metabolite secrete extracellular vesicles that promote epithelial-mesenchymal transition and stemness in breast cancer cells	35
EDARADD promotes colon cancer progression by suppressing E3 ligase Trim21-mediated ubiquitination and degradation of Snail	35
Lipid metabolism reprogramming of CD8+ T cell and therapeutic implications in cancer	35
Identification of SPP1+ macrophages in promoting cancer stemness via vitronectin and CCL15 signals crosstalk in liver cancer	35
Biodistribution and therapeutic efficacy of a gold nanoparticle-based targeted drug delivery system against pancreatic cancer	35
Keloids revisited: Current concepts in treatment and differential diagnosis	35
RNA methyltransferase METTL16: From molecular mechanisms to therapeutic prospects in cancers	35
Histone lactylation dynamics: Unlocking the triad of metabolism, epigenetics, and immune regulation in metastatic cascade of pancreatic cancer	34
Single-cell transcriptomics reveals intratumor heterogeneity and the potential roles of cancer stem cells and myCAFs in colorectal cancer liver metastasis and recurrence	34
PI3K PROTAC overcomes the lapatinib resistance in PIK3CA-mutant HER2 positive breast cancer	34
Revisiting the advances and challenges in the clinical applications of extracellular vesicles in cancer	34
TFAP2C-DDR1 axis regulates resistance to CDK4/6 inhibitor in breast cancer	34
SIK1 promotes ferroptosis resistance in pancreatic cancer via HDAC5-STAT6-SLC7A11 axis	34
The eIF3a translational control axis in the Wnt/β-catenin signaling pathway and colon tumorigenesis	34
Targeting tumor-intrinsic SLC16A3 to enhance anti-PD-1 efficacy via tumor immune microenvironment reprogramming	34
Editorial Board	33
Editorial Board	33
Cell adhesion molecule ITGB2 promotes CAR-T cell therapy in B-cell malignancies	33
Dual blockade of PD-1 and CTLA-4 generates long-lasting immunity against irradiated glioblastoma	33
CHEK2 deficiency increase the response to PD-1 inhibitors by affecting the tumor immune microenvironment	33
Editorial Board	33
Inflammatory cytokine-regulated LNCPTCTS suppresses thyroid cancer progression via enhancing Snail nuclear export	33
Inhibition of the endosomal recycling pathway downregulates HER2 activation and overcomes resistance to tyrosine kinase inhibitors in HER2-positive breast cancer	33
Cancer-associated fibroblasts: A key target to snatch victory from defeat in therapy resistance associated with the pancreatic cancer stroma	33
Editorial Board	33
Harnessing genetic interactions for prediction of immune checkpoint inhibitors response signature in cancer cells	33
A novel microenvironment regulated system CAR-T (MRS.CAR-T) for immunotherapeutic treatment of esophageal squamous carcinoma	32
Tumor-derived extracellular vesicles induce invalid cytokine release and exhaustion of CD19 CAR-T Cells	32
PPDPF promotes esophageal squamous cell carcinoma progression by blocking PCCA binding to PCCB and inhibiting methionine catabolism	32
Disruption of enhancer-driven S100A14 expression promotes esophageal carcinogenesis	32
IgSF protein EWI2 is a tumor suppressor	32
Corrigendum to “Anti-tumor activity of antibody drug conjugate targeting aspartate-β-hydroxylase in pancreatic ductal adenocarcinoma” [Cancer Lett. 449 (2019) 87–98]	32
The nuclear condensates of ESE3/EHF induce cellular senescence without the associated inflammatory secretory phenotype in pancreatic ductal adenocarcinoma	32
Editorial Board	32
Editorial Board	32
Proteolysis of a histone acetyl reader, ATAD2, induces chemoresistance of cancer cells under severe hypoxia by inhibiting cell cycle progression in S phase	32
Corrigendum to “Pharmacological inhibition of DUSP6 suppresses gastric cancer growth and metastasis and overcomes cisplatin resistance” [Cancer Lett. (2018) 412 243–255]	32
ITGB5 facilitates gastric cancer metastasis by promoting TGFBR2 endosomal recycling	31
Drug screening reveals differential drug response in primary and metastatic clear cell sarcoma	31
Cancer stem cells and tumor-associated macrophages: Interactions and therapeutic opportunities	31
The intersections between neuroscience and medulloblastoma	31
Extracellular vesicle biomarkers redefine prostate cancer radiotherapy	31
Confusion about the article: Natural product triptolide induces GSDME-mediated pyroptosis in head and neck cancer through suppressing mitochondrial hexokinase-ΙΙ	31
AXL signal mediates adaptive resistance to KRAS G12C inhibitors in KRAS G12C-mutant tumor cells	31
Microbiome and gartynecologic cancer	31
Evolution and contemporary role of metronomic chemotherapy in the treatment of neuroblastoma	31
Deciphering the immune modulation through deep transcriptomic profiling and therapeutic implications of DNA damage repair pattern in hepatocellular carcinoma	31
Magnolin targeting of the JNK/Sp1/MMP15 signaling axis suppresses cervical cancer microenvironment and metastasis via microbiota modulation	31
Significance of longitudinal Epstein–Barr virus DNA combined with multipoint tumor response for dynamic risk stratification and treatment adaptation in nasopharyngeal carcinoma	31
How to design next-generation of antibody-drug conjugates for cancer treatment: Lessons from unsuccessful clinical trials	31
Metformin inhibits neutrophil extracellular traps-promoted pancreatic carcinogenesis in obese mice	31
Improved survival in pancreatic ductal adenocarcinoma: Exciting promise of multimodal management strategies	30
Corrigendum to “Precision meets repurposing: Innovative approaches in human papillomavirus and Epstein-Barr virus-driven cancer therapy” [Cancer Lett. 607 (2024) 217318]	30
The pro-apoptotic peptide PEP-010 triggers apoptosis in pancreatic tumor models in monotherapy and in combination with gemcitabine independently of the KRAS status	30
Editorial Board	30
Editorial Board	30
Cancer-associated fibroblasts derived amphiregulin promotes HNSCC progression and drug resistance of EGFR inhibitor	30
HMGB1 in the interplay between autophagy and apoptosis in cancer	30
Mechanism of Resistance to a Phase-II Idelalisib-Based Clinical Trial in CLL	30